DJIA39807.37 47.29
S&P 5005254.35 5.86
NASDAQ16379.46 -20.06
Russell 20002120.20 4.00
German DAX18504.51 29.45
FTSE 1007952.62 20.64
CAC 408205.81 1.00
EuroStoxx 505082.85 0.10
Nikkei 22540168.07 -594.66
Hang Seng16541.42 148.58
Shanghai Comp3010.66 17.52
KOSPI2745.82 -9.29
Bloomberg Comm IDX99.49 1.18
WTI Crude-fut87.00 1.32
Brent Crude-fut83.15 1.80
Natural Gas1.76 0.05
Gasoline-fut2.72 0.04
Gold-fut2238.40 26.20
Silver-fut24.92 0.23
Platinum-fut921.10 11.20
Palladium-fut1021.50 26.00
Copper-fut400.70 -0.30
Aluminum-spot1815.00 0.00
Coffee-fut188.85 -1.80
Soybeans-fut1191.50 -1.00
Wheat-fut560.25 12.75
Bitcoin70456.00 -195.00
Ethereum USD3572.73 9.38
Litecoin94.63 0.37
Dogecoin0.22 0.00
EUR/USD1.0808 0.0014
USD/JPY151.26 -0.05
GBP/USD1.2642 0.0011
USD/CHF0.9010 -0.0003
USD IDX104.56 0.19
US 10-Yr TR4.206 0.01
GER 10-Yr TR2.294 0.002
UK 10-Yr TR3.946 0.01
JAP 10-Yr TR0.726 0.02
Fed Funds5.5 0
SOFR5.33 0.01

Connect Money In Your Inbox.

Sign up to get the most important news on the business of financial services delivered daily.

Sub Markets

Property Sectors

Topics

Direct Investment  + M&As  | 
Health Insurer Giant Centene Shuffles Leadership Team, Elevates Ken Fasola to President

Evolent to Buy Magellan Specialty from Government Insurer Centene for $750M

Centene has agreed to sell Magellan Specialty Health to Evolent Health for more than $750 million, the latest move in its broad value creation plan.

The government insurer will receive $600 million, including at least $400 million in cash and the remainder in stock. Centene will bring in an additional $150 million in 2024 should specific performance metrics be reached.

Most of the net proceeds will be used to repurchase stock and the balance to reduce debt. The transaction is expected to close in the first half of 2023.

Centene added Magellan, a specialty benefit management company, as part of its acquisition of Magellen Health, which closed in January.

Centene announced in October increases in year-over-year profits, logging $738 million in the third quarter of this year, up from $584 million a year ago. Total profits for the nine months ended September 30 were up to $1.4 billion.

J.P. Morgan Securities LLC is serving as financial advisor to Centene, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as its legal counsel. Goldman Sachs is serving as financial advisor to Evolent, and Bass Berry & Sims PLC is serving as its legal counsel.

Connect

Inside The Story

Centene

About Joe Palmisano

Joe Palmisano is Editorial Director for Connect Money, where he brings nearly three decades experience of market insights as a financial journalist, analyst and senior portfolio manager for leading financial publications, advisory firms, and hedge funds. In his role as Editorial Director, Joe is responsible for the selection of content and creation of daily business news covering the financial markets, including Alternative Assets, Direct Investment and Financial Advisory services. Before joining Connect Money, Joe was a financial journalist for the Wall Street Journal, regularly publishing feature stories and trend pieces on the foreign exchange, global fixed income and equity markets. Joe parlayed his experience as a financial journalist into roles as a Senior Research Analyst and Portfolio Manager, writing daily and weekly market analysis and managing a FX and US equity portfolio. Joe was also a contributing writer for industry magazines and publications, including SFO Magazine and the CMT Association. Joe earned a B.S.B.A. in Finance from The American University. He holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.

New call-to-action
New call-to-action